Astrana Health, Inc. (NASDAQ:ASTH) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of Astrana Health, Inc. (NASDAQ:ASTH) have been assigned a consensus recommendation of “Moderate Buy” from the nine research firms that are currently covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $45.00.

Several brokerages have recently issued reports on ASTH. Zacks Research upgraded shares of Astrana Health from a “strong sell” rating to a “hold” rating in a research note on Wednesday, March 11th. Needham & Company LLC raised their price target on shares of Astrana Health from $30.00 to $41.00 and gave the stock a “buy” rating in a research note on Friday, May 8th. Barclays upgraded shares of Astrana Health from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $37.00 to $50.00 in a research note on Tuesday, May 26th. Truist Financial raised their price target on shares of Astrana Health from $38.00 to $47.00 and gave the stock a “buy” rating in a research note on Thursday, May 14th. Finally, Robert W. Baird set a $45.00 price target on shares of Astrana Health in a research note on Friday, May 8th.

Institutional Investors Weigh In On Astrana Health

Large investors have recently modified their holdings of the stock. Signaturefd LLC increased its stake in shares of Astrana Health by 57.9% during the 4th quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock worth $26,000 after purchasing an additional 388 shares during the last quarter. GAMMA Investing LLC increased its stake in shares of Astrana Health by 144.7% during the 4th quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock worth $37,000 after purchasing an additional 871 shares during the last quarter. Strs Ohio purchased a new stake in shares of Astrana Health during the 4th quarter worth approximately $40,000. Tower Research Capital LLC TRC increased its stake in shares of Astrana Health by 323.3% during the 2nd quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock worth $115,000 after purchasing an additional 3,517 shares during the last quarter. Finally, State of Wyoming purchased a new stake in shares of Astrana Health during the 2nd quarter worth approximately $132,000. Hedge funds and other institutional investors own 52.77% of the company’s stock.

Astrana Health Price Performance

ASTH opened at $38.29 on Friday. The firm has a market cap of $2.13 billion, a P/E ratio of 62.77 and a beta of 1.00. The firm has a 50-day moving average of $33.98 and a 200 day moving average of $27.19. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.35 and a current ratio of 1.35. Astrana Health has a fifty-two week low of $18.08 and a fifty-two week high of $39.93.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings results on Thursday, May 7th. The company reported $0.74 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.45. The company had revenue of $965.10 million during the quarter, compared to analyst estimates of $949.21 million. Astrana Health had a net margin of 0.86% and a return on equity of 9.22%. The firm’s revenue for the quarter was up 55.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.42 earnings per share. On average, research analysts expect that Astrana Health will post 1.25 EPS for the current year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.